[Vmail-discuss] That's the only way it got approved.

Mon, 17 Dec 2007 20:09:35 +0100

------=_NextPart_000_0006_01C840E8.BEABA750
Content-Type: multipart/alternative;
	boundary="----=_NextPart_001_0007_01C840E8.BEAC6AA0"

------=_NextPart_001_0007_01C840E8.BEAC6AA0
Content-Type: text/plain;
	charset="iso-8859-2"
Content-Transfer-Encoding: quoted-printable

The pill itself is featured on the cover of several magazines! They =
betrayed their responsibility to act as a watchdog for the American =
people.
Meanwhile, which drug, after being launched, quickly became the most =
complained about drug in America? And what do amphetamines do? So, to =
answer your question, yes, Eli Lilly silences dissenters as well.
Here's how Barry Jacobs, a Princeton neuroscientist, describes what =
happens to a person given an SSRI antidepressant. So there was a basic =
need to hide these risks right from the beginning, and that's what was =
done.
And those who come, and don't ask any embarrassing questions, get the =
lobster dinners and maybe they get a little honorarium for attending =
this educational meeting.
That shows up, just in the same way that some people on placebos feel =
better.
An act was passed in which a lot of the FDA's funding came from the drug =
industry: the PDUFA Act, or Prescription Drug User Fee Act.
He said, "I absolutely believed the common wisdom that these =
antipsychotic drugs actually had improved things and that they had =
totally revolutionized how we treated schizophrenia. Are your =
medications making you sick?
SS: In light of the FDA's failure to warn us about Prozac, what about =
their recent negligence on the issue of the risk of suicide in children =
given antidepressants like Paxil?
It really is the answer that unlocks this mystery of why the drugs would =
have this long-term problematic effect. They sent out notices to the =
media questioning his affiliation with Harvard Medical School, etc.
This happened again and again in the pediatric drug trials of =
antidepressants. All these drugs may curb a target symptom slightly more =
effectively than a placebo does for a short period of time, say six =
weeks.
No one wants to talk about that either. All this shows how the American =
public was betrayed and didn't know about all the problems with these =
drugs and why it was kept from them.
But don't they also use their power and money to silence their critics? =
He's written several books on the history of psychopharmacology.
He also managed to get access to some of the trial results and he blew =
the whistle. I have only learned through your many written articles.
What sort of ill effects were people reporting?
They're slow to even put black box warnings on them. RW: That's exactly =
right. The real paradigm is: People diagnosed with mental disorders have =
no known problem with their neurotransmitter systems; and these drugs =
perturb the normal function of neurotransmitters.
And they saw that it looks like these drugs are increasing the risk of =
suicide and there are really no signs of benefits on the target symptoms =
of depression.
That's the only way it got approved.
If we know that we have a scientifically shown risk that these drugs =
increase suicide, shouldn't you at least warn about it?
He's finding that the drugs are being overused and cause severe side =
effects.
They found that as that enlargement occurred, it was associated with a =
worsening of the psychotic symptoms, a worsening of negative symptoms.
It was absolutely covered up. So you were seeing these very problematic =
side effects even at the same time that you were seeing very modest =
efficacy, if any, over placebo in ameliorating depression.
He wrote about this case, and yet in the United States, we got almost no =
news about this secret settlement and this whole perversion of the legal =
process. That's what your expectation would be. All trademarks, =
registered trademarks and servicemarks mentioned on this site are the =
property of their respective owners. Why do you refer to this increase =
as an epidemic?
------=_NextPart_001_0007_01C840E8.BEAC6AA0
Content-Type: text/html;
	charset="iso-8859-2"
Content-Transfer-Encoding: quoted-printable

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD>
<META http-equiv=3DContent-Type content=3D"text/html; =
charset=3Diso-8859-2">
<META content=3D"MSHTML 6.00.2800.1409" name=3DGENERATOR>
<STYLE></STYLE>
</HEAD>
<BODY bgColor=3D#ffffff>
<DIV><FONT face=3DArial size=3D2><IMG alt=3D"invariably" hspace=3D0=20
src=3D"cid:000501c840e0$5ce67c00$d26e2253@gjl" align=3Dbaseline=20
border=3D0></FONT></DIV>
<DIV><FONT face=3DArial size=3D2>The pill itself is featured on the =
cover of several=20
magazines! They betrayed their responsibility to act as a watchdog for =
the American=20
people.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>Meanwhile, which drug, after being =
launched,=20
quickly became the most complained about drug in America? And what do =
amphetamines=20
do? So, to answer your question, yes, Eli Lilly silences dissenters =
as=20
well.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>Here's how Barry Jacobs, a Princeton=20
neuroscientist, describes what happens to a person given an SSRI =
antidepressant. So=20
there was a basic need to hide these risks right from the beginning, and =
that's what=20
was done.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>And those who come, and don't ask any =
embarrassing=20
questions, get the lobster dinners and maybe they get a little =
honorarium for=20
attending this educational meeting.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>That shows up, just in the same way =
that some=20
people on placebos feel better.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>An act was passed in which a lot of the =
FDA's=20
funding came from the drug industry: the PDUFA Act, or Prescription Drug =
User Fee=20
Act.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>He said, "I absolutely believed the =
common wisdom=20
that these antipsychotic drugs actually had improved things and that =
they had=20
totally revolutionized how we treated schizophrenia. Are your =
medications making you=20
sick?</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>SS: In light of the FDA's failure to =
warn us about=20
Prozac, what about their recent negligence on the issue of the risk of =
suicide in=20
children given antidepressants like Paxil?</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>It really is the answer that unlocks =
this mystery=20
of why the drugs would have this long-term problematic effect. They sent =
out notices=20
to the media questioning his affiliation with Harvard Medical School,=20
etc.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>This happened again and again in the =
pediatric drug=20
trials of antidepressants. All these drugs may curb a target symptom =
slightly more=20
effectively than a placebo does for a short period of time, say six=20
weeks.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>No one wants to talk about that either. =
All this=20
shows how the American public was betrayed and didn't know about all the =
problems=20
with these drugs and why it was kept from them.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>But don't they also use their power and =
money to=20
silence their critics? He's written several books on the history of=20
psychopharmacology.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>He also managed to get access to some =
of the trial=20
results and he blew the whistle. I have only learned through your many =
written=20
articles.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>What sort of ill effects were people=20
reporting?</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>They're slow to even put black box =
warnings on=20
them. RW: That's exactly right. The real paradigm is: People diagnosed =
with mental=20
disorders have no known problem with their neurotransmitter systems; and =
these drugs=20
perturb the normal function of neurotransmitters.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>And they saw that it looks like these =
drugs are=20
increasing the risk of suicide and there are really no signs of benefits =
on the=20
target symptoms of depression.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>That's the only way it got =
approved.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>If we know that we have a =
scientifically shown risk=20
that these drugs increase suicide, shouldn't you at least warn about=20
it?</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>He's finding that the drugs are being =
overused and=20
cause severe side effects.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>They found that as that enlargement =
occurred, it=20
was associated with a worsening of the psychotic symptoms, a worsening =
of negative=20
symptoms.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>It was absolutely covered up. So you =
were seeing=20
these very problematic side effects even at the same time that you were =
seeing very=20
modest efficacy, if any, over placebo in ameliorating =
depression.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>He wrote about this case, and yet in =
the United=20
States, we got almost no news about this secret settlement and this =
whole perversion=20
of the legal process. That's what your expectation would be. All =
trademarks,=20
registered trademarks and servicemarks mentioned on this site are the =
property of=20
their respective owners. Why do you refer to this increase as an=20
epidemic?</FONT></DIV></BODY></HTML>

------=_NextPart_001_0007_01C840E8.BEAC6AA0--

------=_NextPart_000_0006_01C840E8.BEABA750
Content-Type: image/gif;
	name="individuality.gif"
Content-Transfer-Encoding: base64
Content-ID: <000501c840e0$5ce67c00$d26e2253@gjl>
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==

------=_NextPart_000_0006_01C840E8.BEABA750--